MolNFT v1 · #108525 · protein
PVHL:ELOB:ELOC in complex with (2S,4R)-1-(3,3-dimethylbutanoyl)-4- hydroxy-N-(4-(4-methylthiazol-5-YL)BENZYL)PYRROLIDINE-2-carboxamide (ligand 5)
4W9F · Transcription elongation factor B polypeptide 2: “PVHL:ELOB:ELOC in complex with (2S,4R)-1-(3,3-dimethylbutanoyl)-4…”. X-ray diffraction, 1 ligand (3JU), 9 pockets (best druggability 0.72). MolNFT v1 #108525 on GenesisL1: 3D…
- PDB
- 4W9F
- Type
- protein
- Length
- 1,317 residues
- Chains
- 12
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Transcription elongation factor B polypeptide 2; Transcription elongation factor B…
- UniProt
- Q15370, Q15369, P40337
- Ligands
- 3JU
- Pockets
- 9 · best druggability 0.72
Structure
x-ray diffraction · 11 distinct chains · 29% helix, 27% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Transcription elongation factor B polypeptide 2 | protein | 104 | 17% helix, 35% strand | Q15370 |
| B | Transcription elongation factor B polypeptide 1 | protein | 87 | 48% helix, 15% strand | Q15369 |
| C | Von hippel-lindau disease tumor suppressor | protein | 141 | 24% helix, 30% strand | P40337 |
| D | Transcription elongation factor B polypeptide 2 | protein | 99 | 15% helix, 34% strand | Q15370 |
| E | Transcription elongation factor B polypeptide 1 | protein | 87 | 45% helix, 15% strand | Q15369 |
| F | Von hippel-lindau disease tumor suppressor | protein | 142 | 27% helix, 30% strand | P40337 |
| G, J | Transcription elongation factor B polypeptide 2 | protein | 103 | 15% helix, 39% strand | Q15370 |
| H | Transcription elongation factor B polypeptide 1 | protein | 87 | 48% helix, 15% strand | Q15369 |
| I | Von hippel-lindau disease tumor suppressor | protein | 144 | 26% helix, 29% strand | P40337 |
| K | Transcription elongation factor B polypeptide 1 | protein | 87 | 45% helix, 15% strand | Q15369 |
| L | Von hippel-lindau disease tumor suppressor | protein | 133 | 20% helix, 32% strand | P40337 |
Ligands and binding sites
- 3JU · (4R)-1-(3,3-dimethylbutanoyl)-4-hydroxy-N-[4-(4-methyl-1,3-thiazol-5-yl)benzyl]-L-prolinamide · ligand · 4 copies · chains C, F, I, L
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
9 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 64 | 0.72 | 0.97 | 25 | empty |
| 2 | 150 | 0.52 | 0.79 | 18 | empty |
| 3 | 170 | 0.48 | 0.76 | 23 | 3JU |
| 4 | 165 | 0.46 | 0.76 | 30 | empty |
| 5 | 166 | 0.44 | 0.75 | 25 | empty |
Interfaces
14 interfaces between chains.
- G–H · 1150 Ų buried · 13 hydrogen bonds · protein-protein
- A–B · 1116 Ų buried · 13 hydrogen bonds · protein-protein
- J–K · 1113 Ų buried · 13 hydrogen bonds · protein-protein
- E–F · 1081 Ų buried · 12 hydrogen bonds · protein-protein
- H–I · 1054 Ų buried · 9 hydrogen bonds · protein-protein
Modifications
Observed in the structure: 11 modified (artifact).
Compared structures
- 4W9F · pVHL:EloB:EloC in complex with (2S,4R)-1-(3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylth… · the same entry in another collection · chain K against K, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt Q15370
- Every structure of UniProt Q15369
- Every structure of UniProt P40337
- Elsewhere: RCSB PDB 4W9F · PDBe 4W9F · UniProt Q15370 · UniProt Q15369 · UniProt P40337
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.